[URGNT] Statins Tied to Deadly New Risk!

When it comes to taking statins, I advise taking the “better safe than sorry” approach.

No, that doesn’t mean TAKING statins just in case they could help you… it means NOT taking statins because their benefits don’t outweigh their risks.

This has been an unpopular opinion until very recently…

Studies on statins show just how risky and unnecessary they really are.

And just this week, I have two additional studies to add to the list.

Over the years, studies have come out linking statin use to an increased risk of cataracts, musculoskeletal disorders, neurodegenerative diseases, and cancer.

More recently their connection to type 2 diabetes keeps popping up—with one showing that people taking statins for more than three years having TRIPLE the risk of developing diabetes.

It seems like any time researchers ask the question, “Can statins increase the risk of [fill in the blank],” the answer always comes back, YES.

Now, in a recent study published in the British Journal of Clinical Pharmacology, researchers asked the question, “Can statin drugs increase the risk of skin infections and new-onset diabetes?”

They used data collected from prescription claims between 2001-2011, and they found that (once again) the answer is YES.

They found that using statins was tied to an increased risk of skin and soft tissue infections, as well as an increased risk of diabetes.

No surprise there.

What WAS surprising was that these increased risks showed up after people had been using statins for as little as THREE MONTHS.

Along with the increased risks posed by statins, researchers have started asking another question: “Is it worth it?”

Time and again, the answer is NO.

This time, researchers from the National University of Ireland Galway evaluated the data and concluded that taking statins for primary prevention of heart disease just isn’t worth it.

In fact, in their own words they said that doing so represents “a waste of healthcare resources.”

This is becoming a recurring theme in the medical community—and I hope that it’s making its way into the standard practice of doctors across America.